$169.99
0.670.4%
Last update: Nov 10, 1:24 PM
Gilead Sciences Inc
GILDNASDAQ
The average analyst price target for Gilead Sciences is $150.79, 11.3% below the current price. Of 22 analysts, 18 rate it Buy and 4 Hold. Targets range from $80 to $200. The latest change came on Oct 30, 2026, when UBS raised its price target on Gilead Sciences from $175 to $195 and kept a Buy rating.
Price Target Range — 9 Quarters
Analyst Consensus — 22 Analysts
Rating Trend — Last 9 Months
